Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.



Status:Recruiting
Conditions:Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:1/17/2019
Start Date:May 14, 2013
End Date:May 12, 2023
Contact:Novartis Pharmaceuticals
Phone:1-888-669-6682

Use our guide to learn which trials are right for you!

An Open-label, Multi-center Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study and Are Judged by the Investigator to Benefit From Continued Everolimus Treatment

Study to allow access to everolimus for patients who are on everolimus treatment in a
Novartis-sponsored study and are benefiting from the treatment as judged by the investigator


Inclusion Criteria:

- Patient is currently enrolled in a Novartis-sponsored, CD&MA study receiving
everolimus or everolimus plus Sandostatin LAR Depot and has fulfilled all their
requirements in the parent study

- Patient is currently benefiting from treatment with everolimus, as determined by the
guidelines of the parent protocol.

Exclusion Criteria:

- Patient has been permanently discontinued from everolimus study treatment in the
parent study.

- Patient is receiving everolimus in combination with an unapproved or experimental
treatment

- Other protocol-defined inclusion/exclusion criteria may apply
We found this trial at
14
sites
Stamford, Connecticut 06904
Principal Investigator: Salvatore Del Prete
Phone: 203-276-8447
?
mi
from
Stamford, CT
Click here to add this to my saved trials
Greenwood Village, Colorado
Principal Investigator: Allen Cohn
Phone: 303-730-4751
?
mi
from
Greenwood Village, CO
Click here to add this to my saved trials
Indianapolis, Indiana 46227
Principal Investigator: Hillary Wu
Phone: 317-678-2739
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Lake Success, New York 11042
?
mi
from
Lake Success, NY
Click here to add this to my saved trials
Little Rock, Arkansas 72205
Principal Investigator: Rhonda Gentry
Phone: 501-320-3217
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
?
mi
from
Metairie, LA
Click here to add this to my saved trials
New York, New York 10016
Principal Investigator: Francis P. Arena
Phone: +1 855 737 2873 121
?
mi
from
New York, NY
Click here to add this to my saved trials
Omaha, Nebraska 68154
Principal Investigator: Ralph Hauke
Phone: 402-691-6972
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Portland, Oregon 97239
Principal Investigator: Rodney Pommier
Phone: 503-494-3078
?
mi
from
Portland, OR
Click here to add this to my saved trials
Praha 2, Czech Republic 12808
?
mi
from
Praha 2,
Click here to add this to my saved trials
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials
660 South Euclid Avenue
Saint Louis, Missouri 63110
Principal Investigator: Andrea Wang-Gillam
Phone: 314-747-8085
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Salt Lake City, Utah 84106
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
?
mi
from
Tampa, FL
Click here to add this to my saved trials